Дата публикации статьи в журнале: 11.09.2019
Название журнала: Американский Научный Журнал, Выпуск: № (28) / 2019, Том: 2, Страницы в выпуске: 4-5
Автор: Tbilisi, TSMU Microbiology Department, MD,PhD
Автор: George Obgaidze
Tbilisi, Head of Traumatology Department,TSMU The First University Clinic, MD,PhD
Автор: Inga gvasalia
Tbilisi, TSMU The First University Clinic, Physician of infectious diseases, MD,PhD
Анотация: Abstract. Staphylococcus aureus (S. aureus) is an independent risk factor for orthopaedic surgical site
infection (SSI). There is a strong epidemiologic association between nasopharyngeal carriage of S. aureus and
development of S. aureus SSIs. Carriers are two to nine times more likely to acquire S. aureus SSIs than noncarriers
. Staphylococcus colonizing nasal or pharyngeal sites can become virulent and cause severe infections. In this
study, We retrospectively studed both pharyngeal and nasal colonisation of St.aureus in 59 outpatients who visited
TSMU the first university clinic traumatology department for screening purposes before orthopedic implant
surgery. One swab was taken from the nostrils which was rotated gently in both nostrils, and one swab was taken
from the pharynx by sweeping both tonsils. Specimens were inoculated onto manitol-salt and 5% sheep blood agar
palate, which were incubated for 20 to 28 hours at 35°C to 37°C. After 24 hours negative plates were incubated
for an additional 24 hours. The absolute S. aureus carriage was 25.42%, as 15 out of the 59 patients had S. aureus
in the nose. 2 patients had SA both in the throat and nose. 1 patient had Candida albicans in the throat swab.
Screening does not yielded positive nasal cultures MRSA . Thus, the nasal carrier rate was marginally significantly
higher than that in the pharynx. We also eveluated antibiotic susceptibility test results which showed resistance to
erythromycin, tetracycline,clindamycin and clarithromycine.
DOI:
Данные для цитирования: Tamar Didbaridze George Obgaidze Inga gvasalia. EVELUATION OF PREOPERATIVE NASOPHARYNGEAL COLONISATION OF STAPHYLOCOCCUS AUREUS IN ORTHOPAEDIC IMPLANT SURGERY. Американский Научный Журнал. Биологические науки. 11.09.2019; № (28) / 2019(2):4-5.
View Fullscreen
Список литературы: References:
1. Arciola CR, Cervellati M, Pirini V, Gamberini
S, Montanaro L. Staphylococci in orthopaedic surgical
wounds. New Microbiol. 2001;24:365–369
2. Calia FM, Wolinsky E, Mortimer EA Jr,
Abrams JS, Rammelkamp CH Jr. Importance of the
carrier state as a source of Staphylococcus aureus in
wound sepsis. J Hyg (Lond). 1969;67:49–57.
3. Weinstein HJ. The relation between the nasalstaphylococcal-carrier state and the incidence of
postoperative complications. N Engl J Med.
1959;260:1303–1308. [PubMed]
4. 24. Wertheim HF, Melles DC, Vos MC, van
Leeuwen W, van Belkum A, Verbrugh HA, Nouwen
JL. The role of nasal carriage in Staphylococcus aureus
infections. Lancet Infect Dis. 2005;5–12:751–762.
5. Kluytmans J. Reduction of surgical site
infections in major surgery by elimination of nasal
carriage of Staphylococcus aureus. J Hosp Infect.
1998;40(suppl B):S25–29. [
6. Kalmeijer MD, van Nieuwland-Bollen E,
Bogaers-Hofman D, de Baere GA. Nasal carriage of
Staphylococcus aureus is a major risk factor for
surgical-site infections in orthopedic surgery. Infect
Control Hosp Epidemiol. 2000;21:319–323.
7. Mangram AJ, Horan TC, Pearson ML, Silver
LC, Jarvis WR. Guideline for prevention of surgical
site infection, 1999. Centers for Disease Control and
Prevention (CDC) Hospital Infection Control Practices
Advisory Committee. Am J Infect Control.
1999;27:97–132; quiz 133–134; discussion 96.
8. Kenner J, O’Connor T, Piantanida N,
Fishbain J, Eberly B, Viscount H, Uyehara C,
Hospenthal D. Rates of carriage of methicillin-resistant
and methicillin-susceptible Staphylococcus aureus in
an outpatient population. Infect Control Hosp
Epidemiol. 2003;24:439–444
9. Ellis MW, Hospenthal DR, Dooley DP, Gray
PJ, Murray CK. Natural history of community-acquired
methicillin-resistant Staphylococcus aureus
colonization and infection in soldiers. Clin Infect Dis.
2004;39-7:971–979
10. Upton A, Lang S, Heffernan H. Mupirocin and
Staphylococcus aureus: a recent paradigm of emerging
antibiotic resistance. J Antimicrob
Chemother. 2003;51:613–617. doi:
10.1093/jac/dkg127. 1036–1043. doi: 10.1086/519929
11. Sandri AM, Dalarosa MG, de Ruschel
Alcantara L, da Silva Elias L, Zavascki AP. Reduction
in incidence of nosocomial methicillin-resistant
Staphylococcus aureus (MRSA) infection in an
intensive care unit: role of treatment with mupirocin
ointment and chlorhexidine baths for nasal carriers of
MRSA. Infect Control Hosp Epidemiol. 2006;27:185–
187. doi: 10.1086/500625
12. Perl TM. Prevention of Staphylococcus aureus
infections among surgical patients: beyond traditional
perioperative prophylaxis. Surgery. 2003;134:S10–17.
doi: 10.1016/S0039-6060(03)00391-X.
13. Konvalinka A, Errett L, Fong IW. Impact of
treating Staphylococcus aureus nasal carriers on wound
infections in cardiac surgery. J Hosp
Infect. 2006;64:162–168. doi:
10.1016/j.jhin.2006.06.010.
14. Tong SY, Chen LF, Fowler VG., Jr
Colonization, pathogenicity, host susceptibility, and
therapeutics for Staphylococcus aureus: What is the
clinical relevance? Semin
Immunopathol. 2012;34:185–200. doi:
10.1007/s00281-011-0300-x.
информационное письмо
